Schneider Y J
Université Catholique de Louvain, Département de Biochimie et de Biologie Cellulaire, Brussels, Belgium.
J Immunol Methods. 1989 Jan 6;116(1):65-77. doi: 10.1016/0022-1759(89)90314-1.
Monoclonal antibodies (MAbs), for human use require chemical and biological purity. The best approach seems in vitro cultivation in a serum-, protein-free medium. A basal defined culture medium has been developed to sustain optimal hybridoma cell growth and MAb secretion. It consists of Iscove's Dulbecco's modified, Eagle's, Ham's F12 and NCTC 135 media in a 5:5:1 mixture (v/v/v), to which glucose is added to reach a final concentration of 25 mM, glutamine to 4-6 mM, 2-mercaptoethanol to 50 microM, Pluronic F68 to 0.01-0.1% (w/v), Hepes to 25 mM and NaHCO3 to 3 g/l. Hybridoma cells, derived from Sp 2/0 myeloma and secreting a MAb to a human milk fat globule membrane-associated high molecular weight glycoprotein, were cloned in this medium containing 1% (v/v) fetal calf serum and then sequentially adapted in serum-free medium further supplemented with transferrin and insulin, both at 10 micrograms/ml. Clones producing immunoreactive MAbs secrete a mean of 50 micrograms IgG/ml, i.e., ca. 80% of the concentration reached in Dulbecco's modified Eagle's medium containing 10% serum. When cells were cultured in spinner flasks with a semi-continuous mode of cultivation (with a daily removal of 20% of the volume and its replacement by fresh culture medium), in serum-free medium further supplemented with 10 nM estradiol, a mixture of trace elements and albumin (at 30 micrograms/ml) complexed to linoleic acid, MAb secretion reached 100 micrograms/ml and became equal or higher to that obtained in serum-containing medium. MAb secretion was not decreased and was even significantly increased during the growth phase, when transferrin was replaced by another iron source, i.e., ferric citrate at 500 microM associated with 20 microM ascorbic acid. Finally, deletion of insulin and of albumin-linoleic acid did not affect significantly cell density nor MAb secretion. In conclusion, it appears from this study that semi-continuous cultivation in spinner flasks of hybridoma cells, after cloning and progressive adaptation, in a chemically defined, serum- and protein-free medium, permitted MAb secretion to be increased to a mean of 144 micrograms/ml, i.e., multiplied by a factor of ca. 1.5 compared to culture of these cells in serum-containing medium under the same conditions and by a factor of ca. 2.4 compared to cultivation in serum-containing medium in flasks.
用于人类的单克隆抗体(MAb)需要化学和生物学纯度。最佳方法似乎是在无血清、无蛋白培养基中进行体外培养。已开发出一种基础限定培养基来维持最佳的杂交瘤细胞生长和单克隆抗体分泌。它由伊斯科夫改良的杜尔贝科培养基、伊格尔培养基、哈姆F12培养基和NCTC 135培养基按5:5:1的比例(v/v/v)混合而成,向其中添加葡萄糖使其最终浓度达到25 mM,谷氨酰胺达到4 - 6 mM,2 - 巯基乙醇达到50 μM,普流尼克F68达到0.01 - 0.1%(w/v),羟乙基哌嗪乙磺酸达到25 mM,碳酸氢钠达到3 g/l。从Sp 2/0骨髓瘤细胞系衍生而来、分泌针对人乳脂肪球膜相关高分子量糖蛋白的单克隆抗体的杂交瘤细胞,在含有1%(v/v)胎牛血清的这种培养基中进行克隆,然后依次在进一步添加转铁蛋白和胰岛素(两者浓度均为10 μg/ml)的无血清培养基中适应。产生免疫反应性单克隆抗体的克隆细胞平均分泌50 μg IgG/ml,即约为含有10%血清的杜尔贝科改良伊格尔培养基中所达到浓度的80%。当细胞在转瓶中以半连续培养模式(每天去除20%的体积并用新鲜培养基替换)培养时,在进一步添加10 nM雌二醇、微量元素混合物以及与亚油酸络合的白蛋白(浓度为30 μg/ml)的无血清培养基中,单克隆抗体分泌量达到100 μg/ml,与在含血清培养基中获得的量相等或更高。当用另一种铁源,即500 μM柠檬酸铁与20 μM抗坏血酸联合替代转铁蛋白时,在生长阶段单克隆抗体分泌没有减少甚至显著增加。最后,去除胰岛素以及白蛋白 - 亚油酸对细胞密度和单克隆抗体分泌没有显著影响。总之,从这项研究可以看出,在克隆并逐步适应后,在化学限定的、无血清和无蛋白培养基中对杂交瘤细胞进行转瓶半连续培养,可使单克隆抗体分泌量增加到平均144 μg/ml,即与在相同条件下含血清培养基中培养这些细胞相比增加了约1.5倍,与在培养瓶中含血清培养基中培养相比增加了约2.4倍。